• India surpasses one million cases of coronavirus.
• Executives at Moderna increased their stock sales prior to the release of favorable phase I data, triggering a warning from the US Securities and Exchange Commission about doing “something inappropriate.” Source
• Sinopharm begins the world’s first phase III vaccine trial. Source
• The EU makes advance purchase deals for vaccine candidates from Moderna, Sanofi (300 million doses), J & J (200 million doses), BioNtech and CureVac. Source